Bell Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.5K	Buy	53 +17	+47%	+$5.79K	﹤0.01%	480
2025 Q4	$14.3K	Hold	36	–	–	﹤0.01%	565
2025 Q3	$16.4K	Buy	36 +1	+3%	+$407	﹤0.01%	471
2025 Q2	$11.4K	Sell	35 -2	-5%	-$553	﹤0.01%	623
2025 Q1	$9.99K	Buy	37 +6	+19%	+$1.54K	﹤0.01%	603
2024 Q4	$7.29K	Sell	31 -6	-16%	-$1.58K	﹤0.01%	741
2024 Q3	$10.2K	Buy	37 +2	+6%	+$521	﹤0.01%	614
2024 Q2	$8.51K	Sell	35 -1	-3%	-$158	﹤0.01%	676
2024 Q1	$5.38K	Buy	36 +3	+9%	+$500	﹤0.01%	873
2023 Q4	$6.32K	Sell	33 -5	-13%	-$852	﹤0.01%	753
2023 Q3	$6.73K	Hold	38	–	–	﹤0.01%	665
2023 Q2	$7.22K	Hold	38	–	–	﹤0.01%	635
2023 Q1	$7.61K	Sell	38 -7	-16%	-$1.47K	﹤0.01%	582
2022 Q4	$10.7K	Sell	45 -1	-2%	-$213	﹤0.01%	468
2022 Q3	$9K	Buy	46 +16	+53%	+$3.05K	﹤0.01%	435
2022 Q2	$4K	Buy	+30	New	+$4.26K	﹤0.01%	763
2021 Q4	$3K	Sell	18 -4	-18%	-$743	﹤0.01%	938
2021 Q3	$4K	Buy	+22	New	+$4.13K	﹤0.01%	764